Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study
- PMID: 3192391
- DOI: 10.1007/BF00175408
Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical